Hormones act as messengers in the body, influencing various physiological processes, including metabolism, appetite, and fat storage. Imbalances in these hormones can significantly contribute to weight gain. For example, insulin resistance, often associated with type 2 diabetes, can lead to elevated blood sugar levels and increased fat storage, particularly around the abdomen. Similarly, fluctuations in cortisol, the stress hormone, can trigger cravings for high-calorie foods and promote visceral fat accumulation. In women, hormonal shifts during menopause, characterized by decreased estrogen levels, can slow metabolism and redistribute fat to the abdominal area. Conditions like hypothyroidism, where the thyroid gland doesn't produce enough thyroid hormone, can also slow metabolism, leading to weight gain and difficulty losing weight. Ultimately, the intricate interplay of these hormonal factors underscores their profound impact on weight regulation.

Ozempic (semaglutide) has become a widely recognized name, not just in the medical community, but also in popular culture. Originally developed to treat type 2 diabetes, its potent weight-loss effects have led to a surge in off-label prescriptions. However, with this increased popularity comes a need for a comprehensive understanding of the long-term effects, costs, and potential dangers associated with Ozempic and other semaglutide medications.